Erschienen in:
01.05.2006 | Case Report
Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis
verfasst von:
Christian Zimmer, Martin Beiderlinden, Jürgen Peters
Erschienen in:
Clinical Rheumatology
|
Ausgabe 3/2006
Einloggen, um Zugang zu erhalten
Abstract
Tumor necrosis factor alpha (TNF-α) blocking drugs improve therapy for rheumatic diseases, but the risk of additional immunosuppression and infection is unclear. We report on a patient with rheumatoid arthritis treated with etanercept for 2 years, in addition to methotrexate and prednyliden, who developed fulminant pneumococcal pneumonia with rapid progression to fatal acute respiratory distress syndrome (ARDS) and septic shock. In patients receiving anti-TNF-α therapy, especially in combination with corticosteroids, signs of pulmonary infection should be regarded as very serious, as fulminant pneumonia with ARDS and severe sepsis may develop within 24 h.